Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Longitudinal Observational Study on Rheumatoid Arthritis Patients: Effects of Antirheumatic Treatment on Serum Levels of Survivin

NCT03440892 is registered in ClinicalTrials.gov with Vastra Gotaland Region as lead sponsor.

NCT NCT03440892
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03440892 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Longitudinal Observational Study on Rheumatoid Arthritis Patients: Effects of Antirheumatic Treatment on Serum Levels of Survivin
Lead sponsor
Vastra Gotaland Region
Phase
Observational
Overall status
Unknown status
Start date
November 1, 2017
Completion date
January 31, 2025
Enrollment
2,500 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

rheumatoid arthritis